Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00174980 · ClinicalTrials.gov registry record · Phase 2
Study of Oxycyte in Severe Closed Head Injury
A Phase 2 study, sponsored by Tenax Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT00174980 is a Phase 2 study that was terminated before completion, run by Tenax Therapeutics. The registered enrollment target is 9 participants.
The verdict
NCT00174980, a Phase 2 study, was terminated before completion, sponsored by Tenax Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
Brain damage as a result of decreased oxygen to the brain is found in 80% of patients that die with severe head injuries. Laboratory studies in animals and clinical trials have shown that increasing oxygen in the brain results in better brain oxygen consumption, less cell death, and better functional outcome. This study will test the hypothesis that Oxycyte is an effective way to increase brain oxygen levels in severe head injury.
Interventions
- DRUG Oxycyte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00174980
The ClinicalTrials.gov registry entry for NCT00174980 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tenax Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxycyte is the first listed.
NCT00174980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00174980 about?
NCT00174980 is a clinical study titled "Study of Oxycyte in Severe Closed Head Injury". Brain damage as a result of decreased oxygen to the brain is found in 80% of patients that die with severe head injuries. Laboratory studies in animals and clinical trials have shown that increasing oxygen in the brain results in better brain oxygen consumption, less cell death, and better functiona...
What is the current status of trial NCT00174980?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2005-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00174980?
The interventions under investigation include: Oxycyte (DRUG).
Who is sponsoring clinical trial NCT00174980?
This trial is sponsored by Tenax Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.